Kolexia
Maillard Sophie
Oncologie radiothérapie
Centre Hospitalier de Lens
Lens, France
48 Activités
221 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la tête et du cou Tumeurs du col de l'utérus Carcinomes Tumeurs épidermoïdes Tumeurs de la thyroïde Maladie résiduelle {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Industries

MundiPharma
4 collaboration(s)
Dernière en 2021
MSD
3 collaboration(s)
Dernière en 2020
Sanofi
3 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2023

Dernières activités

Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   14 avril 2023
Randomized Trial Assessing the Impact of Routine Assessment of Health-Related Quality of Life in Patients with Head and Neck Cancer.
Cancers   29 juillet 2021
Harmonization of practices between radiotherapy centres in the Nord and Pas-de-Calais regions (France): A three-year evaluation.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   11 janvier 2019
Are dietary reports in a case-control study on thyroid cancer biased by risk perception of Chernobyl fallout?
Revue d'epidemiologie et de sante publique   01 juin 2017
Adaptive radiation therapy in head and neck cancer for clinical practice: state of the art and practical challenges.
Japanese journal of radiology   01 décembre 2016
Prospective study of concomitant stereotaxic reirradiation and mitomycin with cetuximab for recurrent head and neck cancer.
2015 ASCO Annual Meeting I   20 mai 2015
PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients.
Clinical cancer research : an official journal of the American Association for Cancer Research   27 février 2015
Total radiation dose and overall treatment time are predictive for tumor sterilization in cervical carcinoma treated with chemoradiation and pulsed-dose-rate brachytherapy.
Brachytherapy   07 novembre 2014
Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   04 mars 2010
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}